Pharma Journalist -

Merck, known as MSD outside the United States and Canada, announced a pause in enrollment for the IMPOWER 22 (MK-8591-022) and IMPOWER 24 (MK-8591-024) Phase 3 clinical studies…
Read More...

Quantum Genomics, a biopharmaceutical company specializing in the development of first-in-class drugs directly targeting the brain to treat complex/resistant hypertension, has announced…
Read More...

After nearly two years of virtual meetings the industry looks set to meet face to face and have some really important discussions and you are invited to join them.  SMi’s 9th Annual…
Read More...

Jacobio Pharma (1167.HK) has received the Investigational New Drug (the "IND") approval of the combination therapy of KRAS G12C inhibitor JAB-21822 and Cetuximab injection from the…
Read More...

NJ Biopharmaceuticals LLC an expert provider of chemistry and biopharmaceutical services specializing in bioconjugation, custom synthesis, flow chemistry, and process development has…
Read More...

National Resilience, Inc. (Resilience), a technology focused manufacturing company dedicated to broadening access to complex medicines, announced the acquisition of SwiftScale…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorisation for…
Read More...

Indian Pharma Expo is back and this year, it celebrates its 10th glorious year. The Indian Pharma Expo 2021 is scheduled to be held at 12A Pragati Maidan, New Delhi on the dates 10th…
Read More...

Valneva SE confirmed that the European Medicines Agency (EMA) has started a rolling review of VLA2001, its whole-virus inactivated, adjuvanted COVID-19 vaccine candidate. Valneva…
Read More...

SMi Reports: Registration is open for SM’s inaugural conference: Transdermal and Microneedle Delivery will take place on 24th - 25th January 2022 SMi Group is proud to present the…
Read More...